Navigation Links
Medarex Announces Completion of Sale of Shares in Genmab A/S
Date:2/1/2008

PRINCETON, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it has completed the sale of approximately 2.5 million shares of Genmab A/S which stock is traded on the Copenhagen Stock Exchange. The trade is expected to settle on February 1, 2008. Medarex expects to receive approximately $151.8 million (USD) in net proceeds from the sale. The sale of Genmab shares reduces Medarex's ownership in Genmab to approximately 5.1 percent.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 30 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase III clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its Web site at http://www.medarex.com.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
2. Medarex Announces Election of Marc Rubin as New Board Member
3. Medarex to Present at the UBS Global Life Sciences Conference
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
6. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
7. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
8. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
9. Rigel Announces Pricing of Public Offering of Common Stock
10. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
11. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
...ote on an article on "The Final Death Knell of Chi... was on the walls of the demise of Searle due to t...final remaining Searle facilities in Chicago. Sinc...in Chicago. , ,Fast forward two years to another a...thousands of jobs, Chicago,s biotech space to trip...
...t gave about $400,000 worth of software to Lad L...k youth and their families. Rob Busch, enterprise ...reception last Friday at the non-profit,s Synergy ... ,Microsoft,s software donation will be used to up...e, including the computers and software programs u...
...c Foundry posted mixed financial numbers for the e...enue while still posting a net loss. , ,Revenues w...previous fiscal year, with unit sales up 74 percen... new product offerings and increased marketing eff...t, however, and the company posted a loss of $4.2 ...
...sin is to attract the presence of major pharmaceut...focus on its own environment, said a panel assembl... Medical-Devices Association. , ,Part of building ...cting large corporations, said WBMA President and ...nior consultant with Cushman and Wakefields Busine...
Other Biology Technology:Searle spirit lives on in Chicago as alumni celebrate at former home 2Searle spirit lives on in Chicago as alumni celebrate at former home 3Searle spirit lives on in Chicago as alumni celebrate at former home 4Searle spirit lives on in Chicago as alumni celebrate at former home 5Panel stresses drawing outside biotech firms to state 2
(Date:9/5/2008)...Newswire/ -- Corporate Safe Specialists (CSS),anno...ompany has hired,Thomas P. Hartmann as Senior Dire...newscom.com/cgi-bin/prnh/20080905/AQF028 ), (Logo...F030LOGO ), Ed McGunn, President and CEO of the C...l help the company achieve its strategic objective...
(Date:9/5/2008)...onal Science Foundation has awarded Iowa State Uni....5 million grant to establish the NSF Engineering ...t Iowa State. , The award is part of the Nationa...g Research Centers (ERC) Program. The third-genera...create university and industry partnerships in res...
(Date:9/5/2008)...animals face the challenge of surviving in a chang...n and Universit Claude Bernard Lyon have shown how...t coast of Scotland responds to two consequences o...e unpredictability of winter storms. Dr. Thomas Ez...es are good and food is plentiful, lambs contribut...
(Date:9/5/2008)...nnovative work on a new type of heart stent sensor...r of mechanical engineering at Virginia Tech, a Na...elopment (CAREER) award of $400,000. , The focu...pecific models and experiments to describe what ha... has a unique type of in situ polymer strain-sensi...
Breaking Biology News(10 mins):Corporate Safe Specialists Launches International Sales Efforts 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 3Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 4Goulbourne earns NSF award to research heart stent sensors 2Goulbourne earns NSF award to research heart stent sensors 3Online Career Site Assists Academia in Its Reach 7327 1Online Career Site Assists Academia in Its Reach 7327 2Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 1Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 2Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 3Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 4Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 5Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 6UltraShape Appoints Assaf Eyal as President 26 CEO 7326 1UltraShape Appoints Assaf Eyal as President 26 CEO 7326 2UltraShape Appoints Assaf Eyal as President 26 CEO 7326 3Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 1Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 2Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 3
... Mice given a relatively new cancer drug can survi...elative of smallpox virus, report scientists suppo...ctious Diseases (NIAID), part of the National Inst...ors, suggest that Gleevec or similar drugs might b...llpox vaccine. The classic smallpox vaccine is mad...
... In this week,s journal Nature, scientists at the ...they have solved one of the "holy grail" puzzles o...ism that insures that the exterior of our bodies i...metrically. , In research with zebra fish, as a mo...s Salk Institute colleagues found that retinoic ac...
... Using a common chemotherapy agent, researchers at...f Pathology and Laboratory Medicine found a way to... cancer, shaking it loose from one location in a c...nother, easier to target area. , The discovery, o...the peer-reviewed journal Molecular Cancer Therape...
... University of Nevada, Reno scientists have ended ...h bark beetles make pheromones: they manufacture t...nts produce and which are often used in perfumes. ... were incapable of making these substances. , "The...romone production," said Gary Blomquist, professor...
Other Biology News:Cancer drug slows poxvirus in mice 2Cancer drug slows poxvirus in mice 3Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 2Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 3UCLA cancer researchers shake loose hidden biomarker 2Researchers discover key gene involved in bark beetle pheromone production 2
...Maker, 1. Modular system for large format and medi...b-cast or precast gels (26 x 20 cm) simultaneously...mple-to-use 1.0-mm or 1.5-mm pre-assembled hinged ... and unloading.Built-in ceramic heat exchanger and...
Edited by P.J. Delves (1997) An up-to-date review of antibody-raising technologies, this volume provides researchers with immediate access to the protocols they require every day.
Request Info
MOUSE ANTI HUMAN FACTOR I
Biology Products: